Kane Biotech Inc. (KNBIF)

Market Cap	4.85M
Revenue (ttm)	1.70M
Net Income (ttm)	4.37M
Shares Out	n/a
EPS (ttm)	0.03
PE Ratio	1.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	1,165
Open	0.0332
Previous Close	0.0350
Day's Range	0.0332 - 0.0332
52-Week Range	0.0332 - 0.1170
Beta	0.18
RSI	31.28
Earnings Date	Aug 29, 2025

About Kane Biotech

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, a biofilm destabilizing formula with continuous activity; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG) for treating wounds and otic infections. Its wound care product portfolio inclu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: KNBIF

Financial Performance

Financial numbers in CAD